Post Reply
601-620 of 8718
good results also down, no result also status quo, if poor results no need to think, medical is a long term business, hopefully owner thinks of full diversification of medical areas eg aesthetics, GP, organs care, transplant etc to haul up the price beyond 0.20.
Any of the bros can speculate what happened to Thomson Medical ? Despite reporting good results, the share went into a downtrend.
ask him to privatise $1 can or not?
positivity88 ( Date: 13-Feb-2023 13:31) Posted:
|
dont think he can privatise below his last acquisition price of 0.088.. whats the time period that he cant do so i am not so sure.
RichardTeo ( Date: 13-Feb-2023 13:28) Posted:
|
Hopefully he read the message and makes TH very valuable with more huge profitable investments to push it up beyond 0.15
positivity88 ( Date: 13-Feb-2023 11:08) Posted:
|
previously Peter Lim bought at 0.088 right.. that should be first hurdle
Thomson Medical H1 earnings jump 82.6% to S$22.8 million
THOMSON Medical Group (TMG) on Friday (Feb 10) reported an 82.6 per cent year-on-year jump in net profit to S$22.8 million in the half year ended Dec 31.
Revenue for the period rose 26.6 per cent to S$184 million for H1 FY2023, the mainboard-listed condensed interim financial statements showed.
In particular, revenue from its hospital and specialised services segment grew by 14.6 per cent and 41 per cent respectively, with growth mainly attributed to the increase in overall patient loads and higher average bill sizes, TMG said.
In Singapore, revenue was up 28 per cent to S$139.0 million due to an increased contribution from core services such as fertility and paediatric medicine.
Revenue growth was further augmented by the income received from project-related services such as vaccination centres and transitional care facilities.
In Malaysia, revenue rose 23 per cent to S$45 million on the back of higher patient loads and higher case intensity handled. TMG said this was partially attributed to the increased operating capacity at Thomson Hospital Kota Damansara, which had a new wing expansion.
The company noted that there was a 52.8 per cent drop in other income to S$2.3 million due mainly to lower government grants received under the Jobs Support Scheme and tax rebates granted by the Singapore government.
The company&rsquo s total assets as at Dec 31 stood at S$1.34 billion, slightly lower than the S$1.36 billion recorded as at Jun 30, largely due to the depreciation of the Malaysian ringgit against the Singapore dollar.
It also recorded a net decrease in cash and cash equivalents during H1 of S$5.9 million, due mainly to payments for property and equipment, loan interests and lease liabilities, as well as dividend payouts. The decrease was partially offset by the increase in net cash flows from operations of S$52.8 million.
Earnings per share for H1 stood at 0.086 Singapore cents, compared with 0.047 Singapore cents in the year-ago period.
No dividend was declared for the period.
With the transition to an endemic phase of Covid-19. TMG said it has seen an increasing trend of in-patient admissions at its hospitals. Its paediatric business has also shown a &ldquo healthy return&rdquo to pre-pandemic levels.
&ldquo Elective procedures which were deferred during the pandemic are now being performed. We expect this trend to continue into 2023,&rdquo said TMG&rsquo s executive director and group CEO Melvin Heng, adding that there has also been an &ldquo increased emphasis&rdquo on personal health.
The company also said it continues to support the government in several public-private partnerships, such as managing vaccination centres and transitional care facilities.
In Malaysia, TMG is expecting a strong recovery in the healthcare sector, particularly in fertility services.
Overall, it is &ldquo cautiously optimistic&rdquo about its business prospects and is expecting its existing and new business lines to grow, barring any unforeseen circumstances.
possibly heading above 0.10 next week. growth is continuing and will be much stronger this 2023.
spursfan ( Date: 10-Feb-2023 17:47) Posted:
|
Peter Lim group hold 89% n the balance 10% public. Depend on PL order to chiong or not
MEDIA RELEASE
Thomson Medical Group 1H2023 EBITDA rises 41% to $55.5 million
- Group revenue up 27% to $184.0 million on higher patient load, larger average bill size
- Expanded capacity in KL and project-related services also drive revenue growth in Singapore and Malaysia respectively
The Group&rsquo s net profit after tax rose 74% from $14.0 million to $24.3 million.
https://links.sgx.com/1.0.0/corporate-announcements/T20EVQMW6MX809C7/746280_Media%20Release%20-%20Thomson%20Medical%20Group%201H%20FY2023%20EBITDA%20rises%20to%20%2455.5mil.pdf
Thomson Medical Group 1H2023 EBITDA rises 41% to $55.5 million
- Group revenue up 27% to $184.0 million on higher patient load, larger average bill size
- Expanded capacity in KL and project-related services also drive revenue growth in Singapore and Malaysia respectively
The Group&rsquo s net profit after tax rose 74% from $14.0 million to $24.3 million.
https://links.sgx.com/1.0.0/corporate-announcements/T20EVQMW6MX809C7/746280_Media%20Release%20-%20Thomson%20Medical%20Group%201H%20FY2023%20EBITDA%20rises%20to%20%2455.5mil.pdf
Very little.stock own by market players. General Market not interested in this snail stock
should go north to 0.09+, price does not make sense at this low since medical is a MUST VISIT for everyone. Momday masks off coupled with the full opening, more medical visitations from overseas will follow
FishermanSG ( Date: 10-Feb-2023 13:28) Posted:
|
Shd be releasing half year FY results soon. Stock value has dip to 7.2ct. Guess that Thr Lim family busy with nasty divirce case.
FishermanSG ( Date: 22-Nov-2022 10:02) Posted:
|
Not much activity. Toggle at 7.7 to 8.0 ct everday. Yawn !
PL should act expeditiously to raise it above 0.10 for TH to stay relevant for investors. or declare dividend faster and higher. not sure since last announcement of more than 50mil profit and declaring 0.0115 div, yet still no payout in sight. someone perhaps can give indication when will they payout declared. medical business consistency is always there no matter how economies perform as long as countries open up.
Many days has passed. Instead of upswing. TM has that sinking feeling.
divdiend already declared, wondering when is this to be credited. once announced, confident the price will shoot up, since medical business is skyrocketing with the full opening up
going forward very very positive, well said
Everyday ( Date: 31-Aug-2022 10:25) Posted:
|
good to hold tenciously the next quarter, the full opening is creating a deep impact on the rising revenue regionally. Mr Lim is a savvy businessman, no doubt at this share price is indeed quite pathetic, going beyond 0.15 to 0.2 should be the next quarter target. Let' s stay long term and benefit from higher divdend payouts.
Medical business never fails
Medical business never fails
Everyday ( Date: 31-Aug-2022 10:25) Posted:
|
Part of the media release on Aug 29th :
In his new role, Mr Lim is expected to accelerate regional growth through mergers and acquisitions, particularly for core hospital services in fast-growing economies in Southeast Asia. He will continue to spearhead digital transformation at TMG.
Mr Ng added: &ldquo As the healthcare industry progresses and the Group grows in size, it is inevitable that technology will play a pivotal role for the delivery of healthcare services. We see huge opportunities to deploy data analytics to enhance quality of patient care, and to develop new business verticals.
&rdquo Meanwhile, during the period under review, revenue from hospital and specialised services were up 14.1% and 75.0%, respectively. Singapore, which accounted for three-quarters of Group revenue, saw revenue growth of 46.0% to $254.6 million, primarily due to higher income from core services such as obstetrics, gynaecology and paediatrics, and from managing Transitional Care Facilities and Covid-19 treatment facilities. In Malaysia revenue improved 19.8% to $79.1 million on higher patient loads and case intensity, as well as the opening of the new expansion wing at Thomson Hospital Kota Damansara during the second half of the financial year.
As at 30 June 2022, TMG maintained a healthy cash balance of $161.6 million, up from $122.7 million at the end of June 2021, providing the Group with ample funds to see through its committed growth plans and seize new opportunities that may arise. -End -
Full details of financial result and press release :
https://links.sgx.com/1.0.0/corporate-announcements/7KRGFXVT1OS88BDW/977cc8c5bb331f60c193aae7d407aa431ea6bf95c15a6e99f5db90717d778aad
In his new role, Mr Lim is expected to accelerate regional growth through mergers and acquisitions, particularly for core hospital services in fast-growing economies in Southeast Asia. He will continue to spearhead digital transformation at TMG.
Mr Ng added: &ldquo As the healthcare industry progresses and the Group grows in size, it is inevitable that technology will play a pivotal role for the delivery of healthcare services. We see huge opportunities to deploy data analytics to enhance quality of patient care, and to develop new business verticals.
&rdquo Meanwhile, during the period under review, revenue from hospital and specialised services were up 14.1% and 75.0%, respectively. Singapore, which accounted for three-quarters of Group revenue, saw revenue growth of 46.0% to $254.6 million, primarily due to higher income from core services such as obstetrics, gynaecology and paediatrics, and from managing Transitional Care Facilities and Covid-19 treatment facilities. In Malaysia revenue improved 19.8% to $79.1 million on higher patient loads and case intensity, as well as the opening of the new expansion wing at Thomson Hospital Kota Damansara during the second half of the financial year.
As at 30 June 2022, TMG maintained a healthy cash balance of $161.6 million, up from $122.7 million at the end of June 2021, providing the Group with ample funds to see through its committed growth plans and seize new opportunities that may arise. -End -
Full details of financial result and press release :
https://links.sgx.com/1.0.0/corporate-announcements/7KRGFXVT1OS88BDW/977cc8c5bb331f60c193aae7d407aa431ea6bf95c15a6e99f5db90717d778aad